Hot off the Press June 2022
We have collated some great articles and material published over the last month. Click on the links below to read the abstract or download the full paper.
Prevalence and Risk Factors
Patient-reported outcomes one year after positive sentinel lymph node biopsy with or without axillary lymph node dissection in the randomized SENOMAC trial
Risk Factors Associated With Postmastectomy Breast Cancer Lymphedema: A Multicenter Retrospective Analysis - Click for abstract
Risk Factors Associated With Postmastectomy Breast Cancer Lymphedema: A Multicenter Retrospective Analysis
The Association Between the Number of Retrieved Pelvic Lymph Nodes and Ipsilateral Lower Limb Lymphedema in Patients With Gynecologic Cancer- Click for abstract
The Association Between the Number of Retrieved Pelvic Lymph Nodes and Ipsilateral Lower Limb Lymphedema in Patients With Gynecologic Cancer
Methods Four electronic databases (PubMed, EMBASE, CINAHL, Scopus and Google Scholar) were searched from 2001 to February 2021. PRISMA guidelines were followed. The content of the included PROM was evaluated by linking the items of the questionnaires to the International Classifcation of Functioning, Disability and Health (ICF) Core Set for BC using standard linking rules. Methodological quality and measurement properties were assessed using the COSMIN checklist. Qualitative synthesis was used to summarize the evidence on content validity and measurement properties. The overall quality of evidence on each measurement property was provided using GRADE principles.
consistency, testretest, and measurement error for BCSQ-BC, Lymph-ICF, DASH and WHODAS2.
Conclusions Despite a lack of evidence on all-important clinical measurement, two generic (DASH and WHODAS2) and two disease-specifc (BCSQ-BC, Lymph-ICF) PROM demonstrated emerging evidence of adequate measurement properties. The stronger alignment of the BCSQ-BC to the breast cancer ICF core set makes it preferable is a disease-specifc measure. The Lymph-ICF is recommended where lymphedema is a specifc focus. The DASH and WHODAS2 might be most useful where patients with a variety of upper extremity conditions, including breast cancer survivors, are being evaluated in the clinic or research study.
Assessment
A systematic review comparing lymphoscintigraphy and magnetic resonance imaging techniques in the assessment of peripheral lymphedema - click for abstract
A systematic review comparing lymphoscintigraphy and magnetic resonance imaging techniques in the assessment of peripheral lymphedema
Management Strategies
A novel air microfluidics-enabled soft robotic sleeve: Toward realizing innovative lymphedema treatment - click for abstract
A novel air microfluidics-enabled soft robotic sleeve: Toward realizing innovative lymphedema treatment
Association of lymphatic flow velocity with surgical outcomes in patients undergoing lymphovenous anastomosis for breast cancer-related lymphedema - click for abstract
Association of lymphatic flow velocity with surgical outcomes in patients undergoing lymphovenous anastomosis for breast cancer-related lymphedema
Intensive complex physical therapy combined with intermittent pneumatic compression versus Kinesio taping for treating breast cancer-related lymphedema of the upper limb: A randomised cross-over clinical trial- click for abstract
Intensive complex physical therapy combined with intermittent pneumatic compression versus Kinesio taping for treating breast cancer-related lymphedema of the upper limb: A randomised cross-over clinical trial
Early intervention with compression garments prevents progression in mild breast cancer-related arm lymphedema: a randomized controlled trial